Open Access
Numéro
Med Sci (Paris)
Volume 36, Numéro 12, Décembre 2020
Vieillissement et mort : de la cellule à l’individu
Page(s) 1199 - 1206
Section La vieillesse et la mort, problématiques comportementales et sociétales
DOI https://doi.org/10.1051/medsci/2020228
Publié en ligne 9 décembre 2020
  1. http://www.mortality.org/. [Google Scholar]
  2. Jones OR, Scheuerlein A, Salguero-Gómez R, et al. Diversity of ageing across the tree of life. Nature 2014 ; 505 : 169–173. [CrossRef] [PubMed] [Google Scholar]
  3. Graunt J. Natural and political observations made upon the bills of mortality. Hull (1864–1936) CH, ed. Cambridge : Cambridge University Press, 1899. [Google Scholar]
  4. Gompertz B. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Phil Trans Roy Soc 1825 : 513–585. [Google Scholar]
  5. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956 ; 11 : 298–300. [CrossRef] [PubMed] [Google Scholar]
  6. Weismann A (1834–1914). Essais sur l’hérédité et la sélection naturelle. Traduction française par Henry de Varigny. 1892. [Google Scholar]
  7. Medawar PB. An unsolved problem of biology. Med J Aust 1952 ; 1 : 854–855. [Google Scholar]
  8. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957 ; 11 : 398–411. [CrossRef] [Google Scholar]
  9. Kirkwood TB. Evolution of ageing. Nature 1977 ; 270 : 301–304. [CrossRef] [PubMed] [Google Scholar]
  10. Lemoine M. Defining aging. Biology Philosophy 2020; 35 :1–30. [CrossRef] [Google Scholar]
  11. Kenyon C, Chang J, Gensch E, et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993 ; 366 : 461–464. [CrossRef] [PubMed] [Google Scholar]
  12. Clancy DJ, Gems D, Harshman LG, et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001 ; 292 : 104–106. [CrossRef] [PubMed] [Google Scholar]
  13. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003 ; 299 : 572–574. [CrossRef] [PubMed] [Google Scholar]
  14. van Heemst D, Beekman M, Mooijaart SP, et al. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005 ; 4 : 79–85. [CrossRef] [PubMed] [Google Scholar]
  15. Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci USA 2012 ; 109 : 21528–21533. [CrossRef] [Google Scholar]
  16. Angarita SAK, Duarte S, Russell TA, et al. Quantitative measure of intestinal permeability using blue food coloring. J Surg Res 2019 ; 233 : 20–25. [CrossRef] [PubMed] [Google Scholar]
  17. Dambroise E, Monnier L, Ruisheng L, et al. Two phases of aging separated by the Smurf transition as a public path to death. Sci Rep 2016; 6. [CrossRef] [Google Scholar]
  18. Rera M, Vallot C, Lefrançois C. The Smurf transition: new insights on ageing from end-of-life studies in animal models. Curr Opin Oncol 2018 ; 30 : 38–44. [CrossRef] [PubMed] [Google Scholar]
  19. Horne BD, May HT, Muhlestein JB, et al. Exceptional mortality prediction by risk scores from common laboratory tests. Am J Med 2009 ; 122 : 550–558. [CrossRef] [Google Scholar]
  20. Fischer K, Kettunen J, Würtz P, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med 2014 ; 11 : e1001606. [CrossRef] [Google Scholar]
  21. Deelen J, Kettunen J, Fischer K, et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat Commun 2019 ; 10 : 1–8. [Google Scholar]
  22. Pinto JM, Wroblewski KE, Kern DW, et al. Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One 2014 ; 9 : e107541. [CrossRef] [Google Scholar]
  23. de Vries NM, Staal JB, Ravensberg CD, et al. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev 2011 ; 10 : 104–114. [CrossRef] [PubMed] [Google Scholar]
  24. Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and age-related diseases. Biogerontology 2010 ; 11 : 547–563. [CrossRef] [PubMed] [Google Scholar]
  25. Coburn C, Allman E, Mahanti P, et al. Anthranilate fluorescence marks a calcium-propagated necrotic wave that promotes organismal death in C. elegans. PLoS Biol 2013 ; 11 : e1001613. [CrossRef] [PubMed] [Google Scholar]
  26. Yang Y, Santos AL, Xu L, et al. Temporal scaling of aging as an adaptive strategy of Escherichia coli. Sci Adv 2019; 5 : eaaw2069. [CrossRef] [PubMed] [Google Scholar]
  27. Fehrmann S, Paoletti C, Goulev Y, et al. Aging yeast cells undergo a sharp entry into senescence unrelated to the loss of mitochondrial membrane potential. Cell Rep 2013 ; 5 : 1589–1599. [CrossRef] [PubMed] [Google Scholar]
  28. Gaille M, Araneda M, Dubost C, et al. Ethical and social implications of approaching death prediction in humans - when the biology of ageing meets existential issues. BMC Med Ethics 2020; 21 : 64. [CrossRef] [PubMed] [Google Scholar]
  29. Schopenhauer A.. The world as will and representation 1969 ; New York: Dover Publications [Google Scholar]
  30. Lévi-Strauss C. The naked man 1990 ; Chicago: University of Chicago Press 746 p [Google Scholar]
  31. Heidegger M, Stambaugh J, Schmidt DJ. Being and time 2010 ; Albany: State University of New York Press 482 p [Google Scholar]
  32. Epicurus, Inwood B, Gerson LP. The Epicurus reader: selected writings and testimonia. Indianapolis : Hackett, 1994 : 112 p. [Google Scholar]
  33. de Montaigne M.. Les essais 2004 ; Paris: Presses universitaires de France [Google Scholar]
  34. Pascal B, Brunschvicg L, Descotes D, et al. Pensées 2015 ; Paris: Flammarion [Google Scholar]
  35. De M’Uzan M. De, l’art à la mort: itinéraire psychanalytique 1983 ; Paris: Gallimard [Google Scholar]
  36. Raimbault G. L’enfant et la mort: des enfants malades parlent de la mort; problèmes de la clinique du deuil 1977 ; Paris: Privat 222 p [Google Scholar]
  37. Gawande A. Being mortal: medicine and what matters in the end. Macmillan Picador, 2015. [Google Scholar]
  38. Maglio M. Une nouvelle loi pour la fin de vie ?. Détour par l’Italie. Med Sci (Paris) 2019 ; 35 : 258–262. [CrossRef] [Google Scholar]
  39. Gaille M, Horn R. The role of accompagnement in the end-of-life debate in France: from solidarity to autonomy. Theor Med Bioeth 2016 ; 37 : 473–487. [CrossRef] [PubMed] [Google Scholar]
  40. Fouquet C, Brédart A, Bouleuc C. French adaptation of a question prompt list for cancer patients and their carers in supportive and palliative care. Bull Cancer (Paris) 2012; 693–701. [CrossRef] [Google Scholar]
  41. Brandes K, Linn AJ, Butow PN, et al. The characteristics and effectiveness of question prompt list interventions in oncology: a systematic review of the literature: qpl interventions in oncology. Psychooncology 2015 ; 24 : 245–252. [CrossRef] [PubMed] [Google Scholar]
  42. Sébert AL, Schwering KL, Alberti C, et al. Que reste-t-il de l’annonce ? Les enjeux à long terme de l’annonce d’un diagnostic de cancer chez les adolescents et les jeunes adultes : étude qualitative menée auprès de patients traités dans une unité d’hématologie dédiée. Psycho-Oncol 2018 ; 12 : 193–197. [CrossRef] [Google Scholar]
  43. Meyers T. Chroniques de la maladie chronique 2017 ; Paris: PUF 104 p [CrossRef] [Google Scholar]
  44. Wexler A. Mapping fate: a memoir of family, risk, and genetic research 1995 ; Berkeley: University of California Press 321 p [Google Scholar]
  45. Nietzsche F, Wotling P. Le gai savoir 2017 ; Paris: Flammarion [Google Scholar]
  46. Jankélévitch V, Worms F. La mort 2017 ; Paris: Flammarion [Google Scholar]
  47. Houdayer F, Gargiulo M, Frischmann M, et al. The psychological impact of cryptic chromosomal abnormalities diagnosis announcement. Eur J Med Genet 2013 ; 56 : 585–590. [CrossRef] [Google Scholar]
  48. Robins Wahlin TB. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington’s disease. Patient Educ Couns 2007 ; 65 : 279–287. [CrossRef] [PubMed] [Google Scholar]
  49. Gargiulo M, Durr A. Anticiper le handicap. Les risques psychologiques des tests génétiques. Esprit 2014; juillet : 52–65. [CrossRef] [Google Scholar]
  50. Novas C, Rose N. Genetic risk and the birth of the somatic individual. Econ Soc 2000 ; 29 : 485–513. [CrossRef] [Google Scholar]
  51. Gao Q, Yuan F, Yang XA, et al. Development and validation of a new score for predicting functional outcome of neurocritically ill patients: the INCNS score. CNS Neurosci Ther 2020; 26 : 21–9. [CrossRef] [Google Scholar]
  52. Kaur J, Mohanti BK. Transition from curative to palliative care in cancer. Indian J Palliat Care 2011 ; 17 : 1–5. [PubMed] [Google Scholar]
  53. Meyricke R, Sherris M. The determinants of mortality heterogeneity and implications for pricing annuities. Insur Math Econ 2013 ; 53 : 379–387. [CrossRef] [Google Scholar]
  54. European Commission. EU rules on gender-neutral pricing in insurance industry enter into force. 2012. https://ec.europa.eu/commission/presscorner/detail/en/IP_12_1430. [Google Scholar]
  55. Villegas AM, Haberman S. On the modeling and forecasting of socioeconomic mortality differentials: an application to deprivation and mortality in England. North Am Actuar J 2014 ; 18 : 168–193. [CrossRef] [Google Scholar]
  56. Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 2018 ; 392 : 2052–2090. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.